Intensity of Anticoagulant Dosing in Hospitalized Patients with COVID-19

被引:0
|
作者
Gould, M. K. [1 ]
Xu, S. [2 ]
Chen, A. [2 ]
Greene, J. [3 ]
Creekmur, B. [2 ]
Bruxvoort, K. [2 ]
Escobar, G. [3 ]
Adams, J. [4 ]
Langer-Gould, A. [5 ]
Liu, V. [3 ]
Myers, L. C. [6 ]
机构
[1] Kaiser Permanente Bernard J Tyson Sch Med, Hlth Syst Sci, Pasadena, CA USA
[2] Kaiser Permanente Southern Calif, Res & Evaluat, Pasadena, CA USA
[3] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[4] Kaiser Permanente, Ctr Effectiveness & Safety Res, Pasadena, CA USA
[5] Kaiser Permanente Southern Calif, Neurol, Pasadena, CA USA
[6] Kaiser Permanente, Pulm Crit Care, Oakland, CA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2955
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [31] AKI in Hospitalized Patients with COVID-19
    Chan, Lili
    Chaudhary, Kumardeep
    Saha, Aparna
    Chauhan, Kinsuk
    Vaid, Akhil
    Zhao, Shan
    Paranjpe, Ishan
    Somani, Sulaiman
    Richter, Felix
    Miotto, Riccardo
    Lala, Anuradha
    Kia, Arash
    Timsina, Prem
    Li, Li
    Freeman, Robert
    Chen, Rong
    Narula, Jagat
    Just, Allan C.
    Horowitz, Carol
    Fayad, Zahi
    Cordon-Cardo, Carlos
    Schadt, Eric
    Levin, Matthew A.
    Reich, David L.
    Fuster, Valentin
    Murphy, Barbara
    He, John C.
    Charney, Alexander W.
    Boettinger, Erwin P.
    Glicksberg, Benjamin S.
    Coca, Steven G.
    Nadkarni, Girish N.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (01): : 151 - 160
  • [32] Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan
    Fujiwara, Sho
    Nakajima, Mikio
    Kaszynski, Richard H.
    Fukushima, Kazuaki
    Tanaka, Masaru
    Yajima, Keishiro
    Kobayashi, Taiichiro
    Sekiya, Noritaka
    Yamamoto, Yasuhiro
    Miwa, Maki
    Ishihata, Ayaka
    Yamauchi, Yuko
    Yamamoto, Kazuo
    Goto, Hideaki
    Imamura, Akifumi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (06) : 869 - 875
  • [33] Lupus anticoagulant is frequent in patients with Covid-19
    Harzallah, Ines
    Debliquis, Agathe
    Drenou, Bernard
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (08) : 2064 - 2065
  • [34] Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19
    Robinson, Keith
    Schott, Laura L.
    Matthews, Tom
    Tyagi, Manu
    Ajmani, Vivek B.
    Sacco, Nancy
    Cao, Zhun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [35] Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19
    Robinson, Keith
    Schott, Laura L.
    Matthews, Tom
    Tyagi, Manu
    Ajmani, Vivek B.
    Sacco, Nancy
    Cao, Zhun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [36] Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19
    Robinson, Keith
    Schott, Laura L.
    Matthews, Tom
    Tyagi, Manu
    Ajmani, Vivek B.
    Sacco, Nancy
    Cao, Zhun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [37] Effect of anticoagulant therapy in COVID-19 patients
    R. G. Tieleman
    F. A. Klok
    E. Belfroid
    J. Hoogervorst-Schilp
    I. Schalkers
    C. W. Jansen
    H. J. Siebelink
    Netherlands Heart Journal, 2021, 29 : 35 - 44
  • [38] Effect of anticoagulant therapy in COVID-19 patients
    Tieleman, R. G.
    Klok, F. A.
    Belfroid, E.
    Hoogervorst-Schilp, J.
    Schalkers, I
    Jansen, C. W.
    Siebelink, H. J.
    NETHERLANDS HEART JOURNAL, 2021, 29 (SUPPL 1) : 35 - 44
  • [39] Frequency of lupus anticoagulant in COVID-19 patients
    Harzallah, Ines
    Debliquis, Agathe
    Drenou, Bernard
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2778 - 2778
  • [40] The Impact of Early Phase COVID-19 Vaccination on Hospitalized COVID-19 Patients
    Gullu, Yusuf Taha
    Kulucan, Ebru
    Tuna, Nazmiye Tibel
    Koksal, Nurhan
    Koca, Nizameddin
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 257 (02): : 147 - 151